abbv

AbbVie Announces Fourth Quarter and Full Year Financials

AbbVie Announces Fourth Quarter and Full Year Financials

AbbVie Inc. (NYSE: ABBV) announced Friday financial results for the fourth quarter and full year ended December 31, 2019. Shares of the Company spiked more than 5% Friday morning.Highlights from the report include worldwide net revenues were $8..

AbbVie Inc. Announces that SKYRIZI™ Met Both Primary and All Ranked Secondary Endpoints

AbbVie Inc. Announces that SKYRIZI™ Met Both Primary and All Ranked Secondary Endpoints

AbbVie Inc. (NYSE: ABBV) announced Tuesday that SKYRIZI™ met both primary and all ranked secondary endpoints, which includes superiority at week 52, versus Cosentyx® in a head-to-head Phase 3 study. SKYRIZI showed significantly higher rate..

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Inc. (NYSE: ABBV) reported its fourth quarter financial results for fiscal year 2017. The pharmaceutical company reported better than expected earnings sending shares 13.5 percent before market close on Friday.For the fourth quarter, AbbVie r..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..